Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Conjugate vaccines.

× No keyword cloud information.

29 in total

Review 1. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis.

Authors: J Eskola; J Ward; R Dagan; D Goldblatt; F Zepp; C A Siegrist
Journal: Lancet Date: 1999-12-11 Impact factor: 79.321

2. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis.

Authors: Mary E Ramsay; Nick J Andrews; Caroline L Trotter; Edward B Kaczmarski; Elizabeth Miller
Journal: BMJ Date: 2003-02-15

3. Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis.

Authors: J McVernon; N Andrews; M P E Slack; M E Ramsay
Journal: Lancet Date: 2003-05-03 Impact factor: 79.321

4. Incidence of Haemophilus influenzae type b meningitis during 18 years of vaccine use: observational study using routine hospital data.

Authors: Heikki Peltola; Eeva Salo; Harri Saxén
Journal: BMJ Date: 2004-11-25

5. Carrier-mediated enhancement of cognate T cell help: the basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccine.

Authors: M Pérez-Melgosa; H D Ochs; P S Linsley; J D Laman; M van Meurs; R A Flavell; R K Ernst; S I Miller; C B Wilson
Journal: Eur J Immunol Date: 2001-08 Impact factor: 5.532

6. Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a haemophilus influenzae type B conjugate vaccine in United Kingdom infants.

Authors: S Choo; L Seymour; R Morris; S Quataert; S Lockhart; K Cartwright; A Finn
Journal: Pediatr Infect Dis J Date: 2000-09 Impact factor: 2.129

7. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.

Authors: P T Heath; R Booy; H J Azzopardi; M P Slack; J Bowen-Morris; H Griffiths; M E Ramsay; J J Deeks; E R Moxon
Journal: JAMA Date: 2000-11-08 Impact factor: 56.272

8. Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story.

Authors: E Miller; D Salisbury; M Ramsay
Journal: Vaccine Date: 2001-10-15 Impact factor: 3.641

Review 9. The UK Hib vaccine experience.

Authors: P T Heath; J McVernon
Journal: Arch Dis Child Date: 2002-06 Impact factor: 3.791

10. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors: Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal: N Engl J Med Date: 2003-05-01 Impact factor: 91.245

1 in total

Review 1. Group B Streptococcus vaccine: state of the art.

Authors: Annalisa Nuccitelli; C Daniela Rinaudo; Domenico Maione
Journal: Ther Adv Vaccines Date: 2015-05

1 in total